Related Experiment Video
Updated: Jul 14, 2026

Murine Model of Thoracic Aortic Dissection Induced by Oral β-Aminopropionitrile and Subcutaneous Angiotensin II Infusion
Published on: May 16, 2025
NOX1 deficiency protects from aortic dissection in response to angiotensin II
Gaetan Gavazzi1, Christine Deffert, Candice Trocme
1Department of Geriatrics, University Hospital of Grenoble, Grenoble, France.
Abstract:
Oxidative stress leads to vascular damage and participates in the pathomechanisms of aortic dissection and aneurysm formation. Here we study aortic dissection in mice deficient in the superoxide-generating reduced nicotinamide-adenine dinucleotide phosphate oxidase NOX1. Seven days of treatment with the hypertensive agent angiotensin II (3 mg/kg per day) led to aortic dissection in 23% of wild-type C57BL/6J mice but in only 4% of NOX1-deficient mice (P=0.05). In contrast, treatment of wild-type C57BL/6J mice with the hypertensive agent norepinephrine (12 mg/kg per day), did not lead to aortic dissection or sudden death, suggesting that hypertension is not sufficient to cause aortic dissection. Interestingly, norepinephrine-dependent blood pressure elevations were conserved in NOX1-deficient mice, demonstrating that, different from angiotensin II, it acts through NOX1-independent hypertensive mechanisms. The resistance of NOX1-deficient mice to angiotensin II-induced aortic dissection suggests a role for NOX1-dependent alterations of the vascular wall. We, therefore, studied gene expression and protease/inhibitor equilibrium. cDNA array analysis demonstrated differential effects of angiotensin II on gene expression in wild-type and NOX1-deficient mice. Tissue inhibitor of metalloproteinase 1 was increased both on the mRNA and the protein level in aortas from NOX1-deficient mice. Thus, our results demonstrate that NOX1 is involved in the mechanisms of angiotensin II-dependent aortic dissection. As one underlying mechanism, we have identified NOX1-dependent suppression of tissue inhibitor of metalloproteinase 1 expression, which could lead to tissue damage through an altered protease/inhibitor balance.
Insights
Reduced nicotinamide-adenine dinucleotide phosphate oxidase (NOX1) deficiency protects against angiotensin II-induced aortic dissection in mice. This protection is linked to NOX1-dependent suppression of tissue inhibitor of metalloproteinase 1.
Area of Science:
- Vascular Biology
- Oxidative Stress Biology
- Cardiovascular Research
Background:
- Oxidative stress contributes to vascular damage and the development of aortic dissection and aneurysms.
- The role of specific oxidative stress enzymes, like NOX1, in aortic dissection pathogenesis requires further elucidation.
Purpose of the Study:
- To investigate the role of the superoxide-generating enzyme NOX1 in angiotensin II-induced aortic dissection.
- To explore the underlying molecular mechanisms, including gene expression and protease/inhibitor balance, in NOX1-deficient mice.
Main Methods:
- Utilized a mouse model of angiotensin II-induced hypertension to study aortic dissection.
- Compared the incidence of aortic dissection in wild-type and NOX1-deficient mice.
- Analyzed gene expression and protein levels of key regulators, such as tissue inhibitor of metalloproteinase 1.
Main Results:
- NOX1-deficient mice showed significantly reduced incidence of aortic dissection compared to wild-type mice when treated with angiotensin II (4% vs. 23%).
- Hypertension induced by norepinephrine did not cause aortic dissection in either wild-type or NOX1-deficient mice, indicating hypertension alone is insufficient.
- NOX1 deficiency led to increased expression of tissue inhibitor of metalloproteinase 1 at both mRNA and protein levels in the aorta.
Conclusions:
- NOX1 plays a critical role in the pathogenesis of angiotensin II-dependent aortic dissection.
- NOX1-mediated suppression of tissue inhibitor of metalloproteinase 1 is a key mechanism contributing to vascular damage and aortic dissection.
- Targeting NOX1 or restoring tissue inhibitor of metalloproteinase 1 may offer therapeutic strategies for preventing aortic dissection.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of β1 Blockers

